Skip to main content
Top
Published in: Rheumatology International 4/2020

01-04-2020 | Knee Osteoarthritis | Observational Research

DNA methyltransferase genes polymorphisms are associated with primary knee osteoarthritis: a matched case–control study

Authors: Antonio Miranda-Duarte, Verónica Marusa Borgonio-Cuadra, Norma Celia González-Huerta, Emma Xochitl Rojas-Toledo, Juan Francisco Ahumada-Pérez, Matvey Sosa-Arellano, Eugenio Morales-Hernández, Nonanzit Pérez-Hernández, José Manuel Rodríguez-Pérez

Published in: Rheumatology International | Issue 4/2020

Login to get access

Abstract

DNA methylation is an epigenetic mechanism involved in the development of primary osteoarthritis (OA). The association between DNA methyltransferases (DNMTs) genes polymorphisms and diseases in which DNA methylation plays a role in their pathogenesis has been described (e.g., cancer); however, its relationship with OA has not been investigated. The aim of this study was to analyze the association between DNMT1, DNMT3A, and DNMT3B polymorphisms with radiologic primary knee OA in Mexican mestizo population. A matched case–control study was conducted (ratio, 1:1). Cases included 244 subjects with definite radiographic knee OA (grade ≥ 2). Controls were matched by age and gender and were subjects with no definite radiographic knee OA/normal (grade < 2). The DNMTs polymorphisms were genotyped by TaqMan allelic discrimination assays. Conditional logistic regression was carried out, and the genetic association was tested under co-dominant, dominant, and recessive inheritance models. Haplotypes for DNMT1 polymorphisms were constructed and their associations were also tested. The CC genotypes of rs2228611 and rs2228612 of DNMT1 were associated with a lower risk for primary knee OA under a co-dominant and a recessive model [OR (95% CI) 0.4 (0.2–0.8)/0.5 (0.3–0.8) and 0.3 (0.1–0.8)/0.3 (0.1–0.7), respectively]. The CT haplotype of DNMT1 polymorphisms was associated with a lower risk [OR (95% CI) 0.71 (0.51–0.97)]. The CC genotype of rs2424913 of DNMT3B was associated with an increased risk under a co-dominant and a dominant model [OR (95% CI) 3.0 (1.1–8.0), and 1.6 (1.1–2.4), respectively]. Our results show that DNMTs polymorphisms are associated with primary knee OA.
Literature
14.
go back to reference Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915–926CrossRefPubMed Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915–926CrossRefPubMed
15.
go back to reference Lei H, Oh SP, Okano M et al (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122:3195–3205PubMed Lei H, Oh SP, Okano M et al (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122:3195–3205PubMed
29.
go back to reference Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049CrossRefPubMed Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049CrossRefPubMed
34.
go back to reference Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247–57CrossRefPubMed Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247–57CrossRefPubMed
37.
go back to reference Stock M, Menges S, Eitzinger N et al (2017) A dual role of upper zone of growth plate and cartilage matrix-associated protein in human and mouse osteoarthritic cartilage: inhibition of aggrecanases and promotion of bone turnover. Arthritis Rheumatol (Hobok) 69:1233–1245. https://doi.org/10.1002/art.40042 CrossRef Stock M, Menges S, Eitzinger N et al (2017) A dual role of upper zone of growth plate and cartilage matrix-associated protein in human and mouse osteoarthritic cartilage: inhibition of aggrecanases and promotion of bone turnover. Arthritis Rheumatol (Hobok) 69:1233–1245. https://​doi.​org/​10.​1002/​art.​40042 CrossRef
43.
go back to reference Yanagisawa Y, Ito E, Yuasa Y, Maruyama K (2002) The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. Biochim Biophys Acta 1577:457–65CrossRefPubMed Yanagisawa Y, Ito E, Yuasa Y, Maruyama K (2002) The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. Biochim Biophys Acta 1577:457–65CrossRefPubMed
Metadata
Title
DNA methyltransferase genes polymorphisms are associated with primary knee osteoarthritis: a matched case–control study
Authors
Antonio Miranda-Duarte
Verónica Marusa Borgonio-Cuadra
Norma Celia González-Huerta
Emma Xochitl Rojas-Toledo
Juan Francisco Ahumada-Pérez
Matvey Sosa-Arellano
Eugenio Morales-Hernández
Nonanzit Pérez-Hernández
José Manuel Rodríguez-Pérez
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 4/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04474-7

Other articles of this Issue 4/2020

Rheumatology International 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine